down arrow

Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
960.45
63.55 (7.09%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 51.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Net Sales
362.15
297.46
252.67
226.21
203.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
362.15
297.46
252.67
226.21
203.60
Raw Material Cost
243.77
180.06
174.84
148.39
123.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-17.94
7.32
-13.99
-2.01
6.99
Employee Cost
58.82
41.88
34.35
31.16
27.18
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
33.58
32.37
27.63
23.13
19.98
Total Expenditure (Excl Depreciation)
318.23
261.63
222.83
200.67
177.40
Operating Profit (PBDIT) excl Other Income
43.92
35.83
29.84
25.54
26.20
Other Income
8.97
5.86
5.47
1.91
1.31
Operating Profit (PBDIT)
52.89
41.69
35.31
27.45
27.51
Interest
1.60
0.52
0.47
0.92
0.56
Exceptional Items
0.00
0.00
0.00
0.00
-21.62
Gross Profit (PBDT)
51.29
41.17
34.84
26.53
5.33
Depreciation
12.71
6.52
5.66
6.10
6.27
Profit Before Tax
38.60
34.65
29.18
20.43
-0.93
Tax
9.46
8.56
7.19
5.44
1.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.14
26.10
21.99
14.99
-2.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
29.14
26.10
21.99
14.99
-2.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.26
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.14
26.10
21.99
14.99
-2.34
Equity Capital
10.45
10.40
10.90
10.90
91.00
Face Value
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
360.06
0.00
Earnings per share (EPS)
13.94
12.55
10.09
6.88
-0.09
Diluted Earnings per share
13.85
12.54
10.09
7.79
-1.29
Operating Profit Margin (Excl OI)
12.13%
12.05%
11.81%
11.29%
12.87%
Gross Profit Margin
14.16%
13.84%
13.79%
11.73%
2.62%
PAT Margin
8.05%
8.77%
8.7%
6.63%
-1.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 21.75% vs 17.73% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 11.65% vs 18.69% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 22.58% vs 20.07% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 207.69% vs 10.64% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Windlas Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
362.15
5,969.93
-5,607.78
-93.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
362.15
5,969.93
-5,607.78
-93.93%
Raw Material Cost
243.77
934.97
-691.20
-73.93%
Purchase of Finished goods
0.00
857.27
-857.27
-100.00%
(Increase) / Decrease In Stocks
-17.94
-104.82
86.88
82.88%
Employee Cost
58.82
1,280.21
-1,221.39
-95.41%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
33.58
1,470.50
-1,436.92
-97.72%
Total Expenditure (Excl Depreciation)
318.23
4,438.13
-4,119.90
-92.83%
Operating Profit (PBDIT) excl Other Income
43.92
1,531.80
-1,487.88
-97.13%
Other Income
8.97
210.03
-201.06
-95.73%
Operating Profit (PBDIT)
52.89
1,741.83
-1,688.94
-96.96%
Interest
1.60
18.01
-16.41
-91.12%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
51.29
1,723.82
-1,672.53
-97.02%
Depreciation
12.71
213.36
-200.65
-94.04%
Profit Before Tax
38.60
1,510.46
-1,471.86
-97.44%
Tax
9.46
314.99
-305.53
-97.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
29.14
1,195.47
-1,166.33
-97.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
29.14
1,195.47
-1,166.33
-97.56%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.14
1,189.96
-1,160.82
-97.55%
Equity Capital
10.45
40.06
-29.61
-73.91%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.94
29.70
-15.76
-53.06%
Diluted Earnings per share
13.85
29.65
-15.80
-53.29%
Operating Profit Margin (Excl OI)
12.13%
25.66%
0.00
-13.53%
Gross Profit Margin
14.16%
28.88%
0.00
-14.72%
PAT Margin
8.05%
20.13%
0.00
-12.08%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 362.15 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 21.75% vs 17.73% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 29.14 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 11.65% vs 18.69% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.92 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 22.58% vs 20.07% in Sep 2023

Half Yearly - Interest
Interest 1.60 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 207.69% vs 10.64% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.13%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023